Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd (000710)

Market Closed
20 Dec, 06:57
XSHE XSHE
¥
10. 15
-0.03
-0.29%
¥
3.36B Market Cap
- P/E Ratio
0% Div Yield
15,033,400 Volume
0 Eps
¥ 10.18
Previous Close
Day Range
10.08 10.4
Year Range
5.4 13.16
Want to track 000710 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

000710 Chart

Berry Genomics Co.,Ltd Profile

Biotechnology Industry
Healthcare Sector
Dr. Yang Gao CEO
XSHE Exchange
CNE000000PN7 ISIN
CN Country
1,448 Employees
- Last Dividend
1 Sep 2006 Last Split
2 Apr 1997 IPO Date

Overview

Berry Genomics Co.,Ltd is a pioneering life science and genomics company based in Beijing, China, established in 1997. It specializes in the development and commercialization of genetic testing technologies for clinical applications across China. Berry Genomics provides a comprehensive suite of services and products, catering to the needs of hospitals, research institutions, universities, and enterprises not only throughout Mainland China but also in Hong Kong, Macao, Taiwan, Southeast Asia, the Middle East, and Australia. The company leverages advanced genetic testing and sequencing technologies to offer innovative solutions in non-invasive DNA prenatal testing, genetic disease testing, and tumor genetic testing, alongside providing cutting-edge laboratory solutions and big data services to further scientific research and healthcare.

Products and Services

  • Non-invasive DNA Prenatal Testing Service: This service offers a safe and accurate testing solution for expectant mothers to identify potential genetic conditions in the fetus without posing any risk to the baby.
  • Genetic Disease Testing: Comprehensive tests designed to detect genetic diseases, aiding in early diagnosis and management of hereditary conditions.
  • Tumor Genetic Testing: Advanced testing services to analyze genetic mutations in tumors, supporting targeted cancer treatment strategies and personalized medicine.
  • NextSeq CN500 Gene Sequencer: A cutting-edge sequencing platform that enables high-throughput sequencing, catering to various genomic research needs and clinical applications.
  • Laboratory Solutions: Offers a range of laboratory services, including set-up, management, and optimization, to improve the efficiency and quality of research and clinical practices.
  • Technology Services: Berry Genomics provides a broad array of technology services encompassing:
    • Human Genome Sequencing: High-quality sequencing services for comprehensive human genome analysis.
    • Transcriptional Regulation: Services focused on understanding gene expression and regulatory mechanisms at the transcriptional level.
    • Single Cell/Spatial Sequencing: Cutting-edge techniques for analyzing genetic information at the single-cell level, unlocking insights into cellular function and organization.
    • Animal and Plant Genome Resequencing: Genomic services tailored for animal and plant research, supporting studies in evolution, breeding, and trait selection.
    • Genome Denovo Sequencing: De novo sequencing services for species without a reference genome, enabling the exploration of genetic diversity and evolutionary histories.
    • Microbial Sequencing: Specialized services for sequencing microbial genomes, instrumental in understanding microbial diversity, function, and pathology.
  • Big Data Services: Offering big data analytics and management solutions tailored to genomic research and clinical data, facilitating advanced data-driven discoveries and decisions.

Contact Information

Address: Building 5, Beijing, China
Phone: 86 10 5325 9188